Bank of Nova Scotia’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$212K Sell
1,386
-1,809
-57% -$277K ﹤0.01% 1025
2025
Q4
$440K Buy
+3,195
New +$418K ﹤0.01% 965
2016
Q1
Sell
-57,020
Closed -$4.4M 756
2015
Q4
$4.4M Buy
57,020
+7,360
+15% +$585K 0.02% 259
2015
Q3
$4.1M Buy
49,660
+2,922
+6% +$260K 0.02% 209
2015
Q2
$4.12M Buy
46,738
+16,963
+57% +$1.56M 0.02% 192
2015
Q1
$2.63M Hold
29,775
0.01% 209
2014
Q4
$2.47M Sell
29,775
-10,401
-26% -$862K 0.01% 218
2014
Q3
$3.39M Buy
+40,176
New +$3.25M 0.01% 204

Other funds holding NVS

Bank of Nova Scotia's NVS Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Novartis (NVS) stake by 57% in Q1 2026, selling an estimated $277K and leaving 1,386 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Bank of Nova Scotia first reported a position in NVS in Q3 2014 and has held it in 8 quarters since. The position peaked at $4.4M in Q4 2015. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Bank of Nova Scotia held 1,386 shares of Novartis worth $212K as of Q1 2026.
  • Bank of Nova Scotia sold 1,809 Novartis shares in Q1 2026, an estimated $277K.
  • Novartis made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #1025 holding.
  • Bank of Nova Scotia first reported a position in Novartis in Q3 2014 and has held it in 8 quarters since.
  • Bank of Nova Scotia's Novartis position peaked at $4.4M in Q4 2015.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.